Épisodes

  • Coming Soon: The Threshold

    Coming Soon: The Threshold
    Oct 2 2025
    Global health is facing a critical moment. New scientific breakthroughs are making a huge difference in the fight against epidemics like HIV/AIDS, tuberculosis, and malaria. But funding is down and priorities are shifting. Will these diseases finally be eliminated? Or will they surge instead? On The Threshold, reporters from around the world cover this unfolding crisis from all sides—talking to scientists, politicians, civil society leaders, pharmaceutical executives, and others. The Threshold is a new seven-part Foreign Policy podcast hosted by acclaimed broadcast journalist Henry Bonsu and made possible through funding in part from the Gates Foundation.
    Voir plus Voir moins
    4 min
  • Gates CEO Mark Suzman Is ‘Very Concerned’ About a Health Funding Deadline

    Gates CEO Mark Suzman Is ‘Very Concerned’ About a Health Funding Deadline
    Oct 9 2025
    Welcome to the first episode of The Threshold, a Foreign Policy podcast about the fight to end infectious diseases around the world and the innovations that could get us there. Host Henry Bonsu speaks with Gates CEO Mark Suzman and WACI Health Executive Director Rosemary Mburu about why they’re both optimistic and concerned about the future of disease elimination. And there is a big deadline on their minds that directly impacts the state of global health—which is in a tough place. More than two million people die every year from the world’s biggest infectious diseases: HIV/AIDS, malaria, and tuberculosis. TB alone claimed more than 1.25 million lives in 2023, overtaking COVID as the world’s deadliest infectious disease. On the surface, the fight to end these epidemics is harder now than it’s ever been. Aid for global health dropped more than 20 percent this year, driven in large part by cuts to USAID and British government programs. But for the first time in decades, science is much closer to ending these diseases. Recent advances—including an HIV prevention shot, TB vaccine candidates, and innovative tools to end malaria—could significantly reduce their prevalence. Over the next seven episodes, we’ll explore how new scientific breakthroughs are making a huge difference in the fight against epidemics like HIV/AIDS, tuberculosis, and malaria. But also, we’ll tackle how we can approach global health funding at this geopolitically fraught moment. At a live panel discussion recorded at Foreign Policy’s Health Forum, Suzman and Mburu explain why they believe we could eliminate HIV, TB, and malaria within our lifetimes. Plus, they discuss why they think the Global Fund’s replenishment round in November is critical. The Threshold is made possible in part through funding from the Gates Foundation. (Photo credit: Jonathan Heisler) Guests and organizations: Gates CEO Mark Suzman WACI Health Executive Director Rosemary Mburu
    Voir plus Voir moins
    31 min
  • From Aid to Growth

    From Aid to Growth
    Oct 16 2025
    On today’s show, we are tackling what is possibly the biggest challenge facing global health right now: funding. Host Henry Bonsu speaks with Indonesia Minister of Health Budi Gunadi Sadikin about how he approaches multilateral organizations for financing, as well as his vision for Indonesia. Sadikin was also a longtime banker before going into government. Then, Bonsu talks with Dr. Ngozi Erondu, the technical director of GLIDE, the Global Institute for Disease Elimination. Erondu participated in the first-ever Africa Health Sovereignty Summit this year in Accra, with African government officials and global health partners. They strategized about how to redefine Africa’s role in its own health future—including shifting from external donors towards self-reliance. Erondu explains why she is optimistic about this initiative. The Threshold is made possible in part through funding from the Gates Foundation. Guests and organizations: Budi Gunadi Sadikin, Indonesia Minister of Health Dr. Ngozi Erondu, Technical Director of GLIDE, the Global Institute for Disease Elimination.
    Voir plus Voir moins
    37 min